Xin Lang Cai Jing·2026-02-03 01:25Group 1 - The core viewpoint of the news is that WuXi AppTec experienced a decline in stock price and trading volume, with significant financing activities indicating a mixed sentiment among investors [1][2]. Group 2 - On February 2, WuXi AppTec's stock fell by 2.10%, with a trading volume of 3.425 billion yuan. The financing buy-in amount was 207 million yuan, while the financing repayment was 314 million yuan, resulting in a net financing outflow of 107 million yuan [1]. - As of February 2, the total balance of margin trading for WuXi AppTec was 6.364 billion yuan, with the financing balance of 6.349 billion yuan accounting for 2.75% of the circulating market value, which is above the 70th percentile level over the past year [1]. - In terms of securities lending, on February 2, WuXi AppTec repaid 18,600 shares and sold 4,400 shares, with a selling amount of 410,100 yuan. The remaining securities lending volume was 151,700 shares, with a balance of 14.1344 million yuan, which is below the 20th percentile level over the past year [1]. Group 3 - WuXi AppTec, established on December 1, 2000, and listed on May 8, 2018, provides a comprehensive platform for the discovery, development, and production of small molecule chemical drugs, serving global pharmaceutical companies [2]. - The company's revenue composition includes 78.37% from chemical business, 12.93% from testing services, 6.02% from biological services, and 1.90% from other supplementary services [2]. - For the period from January to September 2025, WuXi AppTec achieved a revenue of 32.857 billion yuan, representing a year-on-year growth of 18.61%, and a net profit attributable to shareholders of 12.076 billion yuan, with a year-on-year increase of 84.84% [2]. Group 4 - Since its A-share listing, WuXi AppTec has distributed a total of 14.06 billion yuan in dividends, with 10.406 billion yuan distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders of WuXi AppTec included Hong Kong Central Clearing Limited as the second-largest shareholder, holding 249 million shares, a decrease of 52.6071 million shares from the previous period [3]. - Other notable shareholders include Huaxia SSE 50 ETF and Huatai-PB CSI 300 ETF, which have also seen reductions in their holdings [3].